Cardiac Pathways Announces European Launch of RPM Tracking System and Chilli* Cooled Ablation Catheters.Health/Medical Writers SUNNYVALE, Calif.--(BW HealthWire)--June 12, 2000 Two German Heart Centers Already Using Products Successfully Cardiac Pathways Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CPWY), a leader in cardiac mapping and ablation technology, today announced the European launch of its RPM(tm) (Realtime Position Management) * Tracking System and its Chilli* RPM cooled ablation catheters. The products will be on display for the first time in Europe at the company's booth during the 12th International Congress at Cardiostim 2000 in Nice, France, June 14-17. In May, the company launched the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approved products in the United States at the North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. Society of Pacing and Electrophysiology annual meeting (NASPE NASPE National Association for Sport and Physical Education NASPE North American Society of Pacing and Electrophysiology NASPE National Association of State Personnel Executives ) in Washington, DC. The European launch follows the company receiving the CE mark, an international symbol that indicates that both the Chilli RPM catheters and RPM Tracking System adhere to quality assurance standards and are in compliance with applicable European medical device directives. The mark also enables the company to market and sell its products in all European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the European Community countries. To date, the RPM Tracking System and Chilli RPM catheters have been sold to the Dresden Heart Center and the German Heart Center, Munich in Europe. The products have also been used successfully at Leiden University Medical Center The Leiden University Medical Center (Dutch: Leids Universitair Medisch Centrum) or LUMC, is the university hospital affiliated with Leiden University, of which it forms the medical faculty. in The Netherlands, and Johns Hopkins University Johns Hopkins University, mainly at Baltimore, Md. Johns Hopkins in 1867 had a group of his associates incorporated as the trustees of a university and a hospital, endowing each with $3.5 million. Daniel C. Medical Center, in Baltimore (United States), for several months. The RPM system, the only commercially available system to integrate real-time, 3D catheter navigation with state-of-the-art ablation technology, is designed to assist physicians in accurately manipulating catheters within the heart during procedures without the aid of fluoroscopy fluoroscopy /flu·o·ros·co·py/ (fldbobr-ros´kah-pe) examination by means of the fluoroscope. fluo·ros·co·py n. Examination by means of a fluoroscope. Also called radioscopy. . It can be used in most diagnostic electrophysiology procedures for real-time visualization of catheters. and offers the potential for reductions in procedure times. The Chilli Cooled Ablation System uses closed-path fluid circulation to control the catheter tip temperature during ablation. By controlling the temperature, electrophysiologists are better able to deliver energy to ablate ab·late v. To remove or destroy the function of. ablate to remove, especially by cutting. ablate verb To remove; excise cardiac tissue responsible for the arrhythmia arrhythmia (ārĭth`mēə), disturbance in the rate or rhythm of the heartbeat. Various arrhythmias can be symptoms of serious heart disorders; however, they are usually of no medical significance except in the presence of . Cardiac Pathways will offer a symposium Friday, June 16, from 2-3:30 p.m. at Cardiostim featuring Prof. Claus Schmitt of the German Heart Center, Dr. Stefan Spitzer of the Dresden Heart Center, Dr. Hugh Calkins from Johns Hopkins, and Dr. Martin Schalij, of Leiden University Medical Center. The doctors will describe their experiences with both the RPM Tracking System and the Chilli catheter. About Cardiac Pathways Cardiac Pathways develops, manufactures and markets minimally invasive systems to diagnose and treat cardiac tachyarrhythmias (abnormally rapid heart rhythms). The company is a pioneer and leader in the development of complete integrated mapping and ablation systems for the diagnosis and treatment of heart rhythm disturbances. Statements included in this release that are not historical or current are "forward-looking statements" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated. The risks and uncertainties which could cause actual results to differ materially from those anticipated in these forward-looking statements include, but are not limited to the Company's ability to gain market acceptance of the Company's products, the Company's ability to successfully obtain regulatory clearance or approvals to market its products, the ability of the Company to cost effectively manufacture and distribute products in commercial quantities, whether the RPM Tracking System and Chilli RPM cooled ablation catheter will be commercially adopted by physicians, whether RPM technology complements existing and emerging treatment modalities and the Company's ability to effectively compete in the field of electrophysiology against its competitors, many of which have substantially greater financial and other resources. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion